Filing Record and Reported Relationship

The relevant EDGAR record is accession 0001806540-26-000001, observed in the registry on 2026-07-26. In that filing, Clare Ozawa is listed with the designation Director in connection with Lycia Therapeutics, Inc.. These labels report the relationship asserted in the filing; they should not be expanded into a more specific operating, ownership, or investment role without separate evidence.